{"id":"W2120110014","doi":"10.1177/1756287212466128","title":"An evidence-based guide to the selection of sequential therapies in metastatic renal cell carcinoma","year":2012,"lang":"en","type":"article","venue":"Therapeutic Advances in Urology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Temsirolimus; Medicine; Sorafenib; Sunitinib; Axitinib; Everolimus; Pazopanib; Renal cell carcinoma; Oncology; Bevacizumab; Internal medicine; Context (archaeology); Targeted therapy; Cancer; Hepatocellular carcinoma; Chemotherapy; PI3K/AKT/mTOR pathway; Discovery and development of mTOR inhibitors","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02543102,0.002039859,0.00529038,0.01476442,0.001018662,0.004650232,0.006341313,0.004251354,0.009731907],"category_scores_gemma":[0.07010723,0.00161316,0.004190758,0.01117089,0.001680397,0.005169327,0.002424233,0.006789218,0.005499188],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004198564,"about_ca_system_score_gemma":0.009734509,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003759091,"about_ca_topic_score_gemma":0.01198446,"domain_scores_codex":[0.9782841,0.008231768,0.009971989,0.0006732806,0.002598199,0.0002406827],"domain_scores_gemma":[0.9369736,0.03776731,0.005656369,0.001382213,0.01662165,0.001598795],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006153594,0.0002812535,0.002115497,0.04369962,0.001592347,0.002005892,0.0006002522,0.002548312,0.001430284,0.01503681,0.4176944,0.5123799],"study_design_scores_gemma":[0.00128631,0.0004426616,0.004682692,0.1008545,0.001826464,0.002816056,0.0007119327,0.004281344,0.0007043642,0.0581192,0.8240781,0.000196361],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[0.002381588,0.5375603,0.1588634,0.207424,0.02075713,0.0162416,0.009803428,0.001630557,0.04533809],"genre_scores_gemma":[0.01674328,0.2511643,0.644325,0.05195046,0.007026639,0.01260157,0.005013274,0.0004252479,0.01075023],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.02543102,"threshold_uncertainty_score":0.1344937,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04916816897671784,"score_gpt":0.3490368308018426,"score_spread":0.2998686618251247,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}